,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
23,.,.,OMIM|novel,.,.,OSS17011400102,256850,Giant axonal neuropathy-1,"1.$$$mimNumber,256850###prefix,####preferredTitle,GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1###inheritance,Autosomal recessive ###headAndNeckFace,Facial weakness ###headAndNeckEyes,Nystagmus ###skeletalSpine,Scoliosis ###skeletalHands,Hand deformities ###skeletalFeet,Foot deformities ;###skeletalFeet,Pes cavus ;###skeletalFeet,Pes planus ;###skeletalFeet,Talipes equinovarus ###skinNailsHairHair,Kinky hair (not a consistent finding) ;###skinNailsHairHair,Curly hair (not a consistent finding) ###neurologicCentralNervousSystem,Pyramidal signs ;###neurologicCentralNervousSystem,Cerebellar signs ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Spastic paraplegia ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Mental retardation (rare) ###neurologicPeripheralNervousSystem,Distal limb muscle weakness due to peripheral neuropathy ;###neurologicPeripheralNervousSystem,Distal limb muscle atrophy due to peripheral neuropathy ;###neurologicPeripheralNervousSystem,Proximal limb weakness ;###neurologicPeripheralNervousSystem,Hyporeflexia of the lower limbs ;###neurologicPeripheralNervousSystem,Areflexia of the lower limbs ;###neurologicPeripheralNervousSystem,Hyporeflexia of the upper limbs (in some patients) ;###neurologicPeripheralNervousSystem,Areflexia of the upper limbs (in some patients) ;###neurologicPeripheralNervousSystem,Sensory and motor axonal neuropathy ;###neurologicPeripheralNervousSystem,Distal sensory impairment ;###neurologicPeripheralNervousSystem,Steppage gait ;###neurologicPeripheralNervousSystem,giant axonal swellings filled with densely packed bundles of 10-nm neurofilaments seen on sural nerve biopsy ;###neurologicPeripheralNervousSystem,Thin myelin sheaths ;###neurologicPeripheralNervousSystem,Loss of myelinated fibers ###miscellaneous,Onset in childhood ;###miscellaneous,Slowly progressive ;###miscellaneous,Variable phenotype ;###miscellaneous,Some patients may lose independent ambulation ;###miscellaneous,See also autosomal dominant giant axonal neuropathy ()###molecularBasis,Caused by mutation in the gigaxonin gene (GAN, )",https://www.omim.org/entry/256850,.,Autosomal recessive,Het,16,81388298,A,G,.,.,PASS,0/1:42:76,55.26,"gg,GGg,GG,,gGgg.,g.gg,g.g,G,,.,ggg,g,,ggg.,,.gGgg,gG.gg,g,..g,,,g,gg,g",missense_variant,GAN,8139,.,NM_022041.3(GAN):c.571A>G(p.Asn191Asp),NM_022041.3,exon3(11),P0=>P-,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-0.43,23.4,7,0.04,http://exac.broadinstitute.org/gene/ENSG00000261609,0.87958,.,0.14,T,0.905,P,0.754,P,0.000,D,1.000,D,5.8,25.5,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell death (GO:0008219)|protein ubiquitination (GO:0016567),Cul3-RING ubiquitin ligase complex (GO:0031463)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856),.,.,.,.,.,85,4,OSS17011400102
28,.,.,OMIM|novel|possible_comhet,.,.,OSS17011400102,604145;613765;608807;611705;603689;600334,"Cardiomyopathy, dilated, 1G;Cardiomyopathy, familial hypertrophic, 9;Muscular dystrophy, limb-girdle, type 2J;Myopathy, early-onset, with fatal cardiomyopathy;Myopathy, proximal, with early respiratory muscle involvement;Tibial muscular dystrophy, tardive","1.$$$mimNumber,608807###prefix,####preferredTitle,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J###inheritance,Autosomal recessive ###cardiovascularHeart,No cardiomyopathy ###muscleSoftTissue,Proximal muscle weakness ;###muscleSoftTissue,Distal muscle weakness, mild ;###muscleSoftTissue,Severe disability within 20 years of onset ;###muscleSoftTissue,Loss of ambulation between third and sixth decade ;###muscleSoftTissue,No facial muscle involvement ;###muscleSoftTissue,EMG shows myopathic changes ;###muscleSoftTissue,Muscle biopsy shows dystrophic changes ;###muscleSoftTissue,Fatty infiltration of affected muscles ;###muscleSoftTissue,Secondary decrease of calpain-3 (CAPN3, ) protein expression in muscle###laboratoryAbnormalities,Normal or increased serum creatine kinase ###miscellaneous,Childhood-onset ;###miscellaneous,Heterozygous titin mutation causes the less-severe tardive tibial muscular dystrophy ();###miscellaneous,Allelic disorder to a form of dilated cardiomyopathy (CMD1G, )###molecularBasis,Caused by mutation in the titin gene (TTN, ) 2.$$$mimNumber,611705###prefix,####preferredTitle,MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; EOMFC###inheritance,Autosomal recessive ###headAndNeckFace,Facial muscle weakness ###headAndNeckEyes,Ptosis ###cardiovascularHeart,Dilated cardiomyopathy ;###cardiovascularHeart,Arrhythmia ###muscleSoftTissue,Delayed motor development ;###muscleSoftTissue,Muscle weakness, generalized, proximal and distal ;###muscleSoftTissue,Calf hypertrophy ;###muscleSoftTissue,Muscle biopsy shows centralized nuclei ;###muscleSoftTissue,Type 1 fiber predominance ;###muscleSoftTissue,Minicore-like lesions with mitochondrial depletion and sarcomeric disorganization ;###muscleSoftTissue,Disruption of the M-line ;###muscleSoftTissue,Dystrophic changes occur later ###laboratoryAbnormalities,Serum creatine kinase may be increased ###miscellaneous,Muscle involvement shows onset at birth or in infancy ;###miscellaneous,Cardiac involvement occurs between 5 and 12 years ;###miscellaneous,Sudden death due to cardiomyopathy ###molecularBasis,Caused by mutation in the titin gene (TTN, ) 3.$$$mimNumber,600334###prefix,####preferredTitle,TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD###inheritance,Autosomal dominant ###muscleSoftTissue,Weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) ;###muscleSoftTissue,Atrophy of the muscles in the anterior compartment of the lower leg ;###muscleSoftTissue,'Steppage' gait ;###muscleSoftTissue,Reduced ankle dorsiflexion ;###muscleSoftTissue,Replacement of affected muscle tissue with fatty tissue ;###muscleSoftTissue,Biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size ;###muscleSoftTissue,Myopathy seen on EMG ###miscellaneous,Adult onset (after age 35 years) ;###miscellaneous,Slow progression without marked disability ;###miscellaneous,Incomplete penetrance ;###miscellaneous,Cardiomyopathy is not a feature ###molecularBasis,Caused by heterozygous mutation in the titin gene (TTN, )",https://www.omim.org/entry/604145;https://www.omim.org/entry/613765;https://www.omim.org/entry/608807;https://www.omim.org/entry/611705;https://www.omim.org/entry/603689;https://www.omim.org/entry/600334,.,Autosomal recessive;Autosomal dominant,Het,2,179582425,AGACACTTGAAG,-,.,.,PASS,0/1:63:133,47.37,".$.$..,.-12AGACACTTGAAG.-12AGACACTTGAAG.-12AGACACTTGAAG.,-12agacacttgaag,-12agacacttgaag,.-12AGACACTTGAAG,.-12AGACACTTGAAG.,.-12AGACACTTGAAG..-12AGACACTTGAAG,.-12AGACACTTGAAG,-12agacacttgaag,-12agacacttgaag.-12AGACACTTGAAG..-12AGACACTTGAAG,,,.-12AGACACTTGAAG.-12AGACACTTGAAG,..-12AGACACTTGAAG.-12AGACACTTGAAG..-12AGACACTTGAAG,-12agacacttgaag.-12AGACACTTGAAG,-12agacacttgaag.-12AGACACTTGAAG,....-12AGACACTTGAAG.,..-12AGACACTTGAAG..-12AGACACTTGAAG..-12AGACACTTGAAG.-12AGACACTTGAAG,-12agacacttgaag,..-12AGACACTTGAAG.-12AGACACTTGAAG.-12AGACACTTGAAG..-12AGACACTTGAAG.,-12agacacttgaag,,-12agacacttgaag.,,.,..-12AGACACTTGAAG,,-12agacacttgaag.,,-12agacacttgaag...-12AGACACTTGAAG,-12agacacttgaag,-12agacacttgaag........-12AGACACTTGAAG.,,.,,....",inframe_deletion;intron_variant;inframe_deletion;intron_variant;intron_variant;inframe_deletion,TTN,7273,.,NM_001267550.1(TTN):c.25165_25176delCTTCAAGTGTCT(p.Leu8389_Ser8392del);NM_003319.4(TTN):c.13282+20373_13282+20384delCTTCAAGTGTCT;NM_133378.4(TTN):c.21433_21444delCTTCAAGTGTCT(p.Leu7145_Ser7148del);NM_133437.3(TTN):c.13858+20373_13858+20384delCTTCAAGTGTCT;NM_133432.3(TTN):c.13657+20373_13657+20384delCTTCAAGTGTCT;NM_001256850.1(TTN):c.24214_24225delCTTCAAGTGTCT(p.Leu8072_Ser8075del),NM_133378.4,exon87(363);intron46(190);exon84(312);intron47(191);intron47(191);exon85(313),.;.;.;.;.;.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-5.48,893.9,247,0.0,http://exac.broadinstitute.org/gene/ENSG00000155657,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,adult heart development (GO:0007512)|blood coagulation (GO:0007596)|cardiac muscle contraction (GO:0060048)|cardiac muscle fiber development (GO:0048739)|cardiac muscle hypertrophy (GO:0003300)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac myofibril assembly (GO:0055003)|detection of muscle stretch (GO:0035995)|forward locomotion (GO:0043056)|in utero embryonic development (GO:0001701)|mitotic chromosome condensation (GO:0007076)|muscle contraction (GO:0006936)|muscle filament sliding (GO:0030049)|platelet activation (GO:0030168)|platelet degranulation (GO:0002576)|regulation of catalytic activity (GO:0050790)|regulation of protein kinase activity (GO:0045859)|regulation of relaxation of cardiac muscle (GO:1901897)|response to calcium ion (GO:0051592)|sarcomere organization (GO:0045214)|sarcomerogenesis (GO:0048769)|skeletal muscle myosin thick filament assembly (GO:0030241)|skeletal muscle thin filament assembly (GO:0030240)|somitogenesis (GO:0001756)|striated muscle contraction (GO:0006941),condensed nuclear chromosome (GO:0000794)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|I band (GO:0031674)|M band (GO:0031430)|nucleus (GO:0005634)|striated muscle thin filament (GO:0005865)|Z disc (GO:0030018),actin filament binding (GO:0051015)|actinin binding (GO:0042805)|ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|enzyme binding (GO:0019899)|identical protein binding (GO:0042802)|muscle alpha-actinin binding (GO:0051371)|protease binding (GO:0002020)|protein kinase binding (GO:0019901)|protein self-association (GO:0043621)|protein serine/threonine kinase activity (GO:0004674)|structural constituent of muscle (GO:0008307)|structural molecule activity conferring elasticity (GO:0097493)|telethonin binding (GO:0031433),.,.,.,.,7,1,OSS17011400102
33,.,.,OMIM|low_frequency|possible_comhet,.,.,OSS17011400102,604145;613765;608807;611705;603689;600334,"Cardiomyopathy, dilated, 1G;Cardiomyopathy, familial hypertrophic, 9;Muscular dystrophy, limb-girdle, type 2J;Myopathy, early-onset, with fatal cardiomyopathy;Myopathy, proximal, with early respiratory muscle involvement;Tibial muscular dystrophy, tardive","1.$$$mimNumber,608807###prefix,####preferredTitle,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J###inheritance,Autosomal recessive ###cardiovascularHeart,No cardiomyopathy ###muscleSoftTissue,Proximal muscle weakness ;###muscleSoftTissue,Distal muscle weakness, mild ;###muscleSoftTissue,Severe disability within 20 years of onset ;###muscleSoftTissue,Loss of ambulation between third and sixth decade ;###muscleSoftTissue,No facial muscle involvement ;###muscleSoftTissue,EMG shows myopathic changes ;###muscleSoftTissue,Muscle biopsy shows dystrophic changes ;###muscleSoftTissue,Fatty infiltration of affected muscles ;###muscleSoftTissue,Secondary decrease of calpain-3 (CAPN3, ) protein expression in muscle###laboratoryAbnormalities,Normal or increased serum creatine kinase ###miscellaneous,Childhood-onset ;###miscellaneous,Heterozygous titin mutation causes the less-severe tardive tibial muscular dystrophy ();###miscellaneous,Allelic disorder to a form of dilated cardiomyopathy (CMD1G, )###molecularBasis,Caused by mutation in the titin gene (TTN, ) 2.$$$mimNumber,611705###prefix,####preferredTitle,MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; EOMFC###inheritance,Autosomal recessive ###headAndNeckFace,Facial muscle weakness ###headAndNeckEyes,Ptosis ###cardiovascularHeart,Dilated cardiomyopathy ;###cardiovascularHeart,Arrhythmia ###muscleSoftTissue,Delayed motor development ;###muscleSoftTissue,Muscle weakness, generalized, proximal and distal ;###muscleSoftTissue,Calf hypertrophy ;###muscleSoftTissue,Muscle biopsy shows centralized nuclei ;###muscleSoftTissue,Type 1 fiber predominance ;###muscleSoftTissue,Minicore-like lesions with mitochondrial depletion and sarcomeric disorganization ;###muscleSoftTissue,Disruption of the M-line ;###muscleSoftTissue,Dystrophic changes occur later ###laboratoryAbnormalities,Serum creatine kinase may be increased ###miscellaneous,Muscle involvement shows onset at birth or in infancy ;###miscellaneous,Cardiac involvement occurs between 5 and 12 years ;###miscellaneous,Sudden death due to cardiomyopathy ###molecularBasis,Caused by mutation in the titin gene (TTN, ) 3.$$$mimNumber,600334###prefix,####preferredTitle,TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD###inheritance,Autosomal dominant ###muscleSoftTissue,Weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) ;###muscleSoftTissue,Atrophy of the muscles in the anterior compartment of the lower leg ;###muscleSoftTissue,'Steppage' gait ;###muscleSoftTissue,Reduced ankle dorsiflexion ;###muscleSoftTissue,Replacement of affected muscle tissue with fatty tissue ;###muscleSoftTissue,Biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size ;###muscleSoftTissue,Myopathy seen on EMG ###miscellaneous,Adult onset (after age 35 years) ;###miscellaneous,Slow progression without marked disability ;###miscellaneous,Incomplete penetrance ;###miscellaneous,Cardiomyopathy is not a feature ###molecularBasis,Caused by heterozygous mutation in the titin gene (TTN, )",https://www.omim.org/entry/604145;https://www.omim.org/entry/613765;https://www.omim.org/entry/608807;https://www.omim.org/entry/611705;https://www.omim.org/entry/603689;https://www.omim.org/entry/600334,.,Autosomal recessive;Autosomal dominant,Het,2,179655526,G,A,.,.,PASS,0/1:80:172,46.51,".$A..AA.A,aaA,,...aA,,a,,,aA,,.A.,,a.AA,,.Aaa.,,AaA,A.A.,A,,A,a.A.Aaaa,a.aa...aaA..a,,a,Aa,,,A.,A,aa,.,,,,a.,,aaa.,,,,aa.a,,aAaA....a,,AaaaAa,aA,a,,a,,^]a^]a",missense_variant;intron_variant;missense_variant;missense_variant;missense_variant;intron_variant;intron_variant,TTN,7273,.,NM_133378.4(TTN):c.1709C>T(p.Ala570Val);NM_133432.3(TTN):c.1663-684C>T;NM_001256850.1(TTN):c.1709C>T(p.Ala570Val);NM_001267550.1(TTN):c.1709C>T(p.Ala570Val);NM_133379.4(TTN):c.1709C>T(p.Ala570Val);NM_133437.3(TTN):c.1663-684C>T;NM_003319.4(TTN):c.1663-684C>T,NM_133378.4,exon11(312);intron10(191);exon11(313);exon11(363);exon11(46);intron10(191);intron10(190),NP=>NP;.;NP=>NP;NP=>NP;NP=>NP;.;.,0.005,0.001,0,0,0.0006,0.0077,0.0004,0.0074,0,63,0.0073,0,64,0.00053,0.0143442622951,7/488,http://exac.broadinstitute.org/variant/2-179655526-G-A,-5.48,893.9,247,0.0,http://exac.broadinstitute.org/gene/ENSG00000155657,0.44249,.,0,D,0.675,P,0.273,B,.,.,1.000,D,4.18,14.28,rs146690035,.,.,.,.,.,.,.,.,.,.,.,.,.,46676,https://www.ncbi.nlm.nih.gov/clinvar/variation/46676,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,adult heart development (GO:0007512)|blood coagulation (GO:0007596)|cardiac muscle contraction (GO:0060048)|cardiac muscle fiber development (GO:0048739)|cardiac muscle hypertrophy (GO:0003300)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac myofibril assembly (GO:0055003)|detection of muscle stretch (GO:0035995)|forward locomotion (GO:0043056)|in utero embryonic development (GO:0001701)|mitotic chromosome condensation (GO:0007076)|muscle contraction (GO:0006936)|muscle filament sliding (GO:0030049)|platelet activation (GO:0030168)|platelet degranulation (GO:0002576)|regulation of catalytic activity (GO:0050790)|regulation of protein kinase activity (GO:0045859)|regulation of relaxation of cardiac muscle (GO:1901897)|response to calcium ion (GO:0051592)|sarcomere organization (GO:0045214)|sarcomerogenesis (GO:0048769)|skeletal muscle myosin thick filament assembly (GO:0030241)|skeletal muscle thin filament assembly (GO:0030240)|somitogenesis (GO:0001756)|striated muscle contraction (GO:0006941),condensed nuclear chromosome (GO:0000794)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|I band (GO:0031674)|M band (GO:0031430)|nucleus (GO:0005634)|striated muscle thin filament (GO:0005865)|Z disc (GO:0030018),actin filament binding (GO:0051015)|actinin binding (GO:0042805)|ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|enzyme binding (GO:0019899)|identical protein binding (GO:0042802)|muscle alpha-actinin binding (GO:0051371)|protease binding (GO:0002020)|protein kinase binding (GO:0019901)|protein self-association (GO:0043621)|protein serine/threonine kinase activity (GO:0004674)|structural constituent of muscle (GO:0008307)|structural molecule activity conferring elasticity (GO:0097493)|telethonin binding (GO:0031433),.,.,.,.,7,1,OSS17011400102
76,.,.,OMIM|low_frequency,Name=LowComplexity,.,OSS17011400102,616538;613818,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9;Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","1.$$$mimNumber,616538###prefix,####preferredTitle,MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9###inheritance,Autosomal recessive ###headAndNeckHead,Macrocephaly ###headAndNeckEyes,Microphthalmia ;###headAndNeckEyes,Buphthalmos ;###headAndNeckEyes,Retinal dystrophy ;###headAndNeckEyes,Cataract ;###headAndNeckEyes,Myopia ;###headAndNeckEyes,Glaucoma ###respiratory,Respiratory failure ###muscleSoftTissue,Hypotonia ;###muscleSoftTissue,Muscular dystrophy ;###muscleSoftTissue,Absence of immunostaining for alpha-dystroglycan (family A) ;###muscleSoftTissue,Absence of immunostaining for alpha- and beta-dystroglycan (family B) ###neurologicCentralNervousSystem,Delayed psychomotor development, severe ;###neurologicCentralNervousSystem,Lack of speech ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Hydrocephalus (family B) ;###neurologicCentralNervousSystem,Thin cortical layer ;###neurologicCentralNervousSystem,Polymicrogyria ;###neurologicCentralNervousSystem,Frontal agyria ;###neurologicCentralNervousSystem,Neuronal migration defects ;###neurologicCentralNervousSystem,Dilated ventricles ;###neurologicCentralNervousSystem,Thin corpus callosum ;###neurologicCentralNervousSystem,Kinking of the pons and brainstem ;###neurologicCentralNervousSystem,Hypoplastic cerebellar vermis ;###neurologicCentralNervousSystem,Cerebellar cysts (family A) ;###neurologicCentralNervousSystem,White matter abnormalities (family A) ;###neurologicCentralNervousSystem,Leukodystrophy (family A) ;###neurologicCentralNervousSystem,Cystic lesions (family A) ;###neurologicCentralNervousSystem,Intracranial calcifications (family B) ###laboratoryAbnormalities,Increased serum creatine kinase ###miscellaneous,Onset in infancy ;###miscellaneous,Variable severity ;###miscellaneous,Death in first days of life (family B) ;###miscellaneous,Two unrelated families have been reported (last curated August 2015) ###molecularBasis,Caused by mutation in the dystrophin-associated glycoprotein-1 gene (DAG1, ) 2.$$$mimNumber,613818###prefix,####preferredTitle,MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9###inheritance,Autosomal recessive ###headAndNeckHead,Small head size (patient A) ###skeletalSpine,Lumbar lordosis (patient A) ###skeletalLimbs,Ankle contractures (patient A) ###muscleSoftTissue,Muscular weakness, limb-girdle (patient A) ;###muscleSoftTissue,Difficulty walking and climbing stairs (patient A) ;###muscleSoftTissue,Gowers sign (patient A) ;###muscleSoftTissue,Muscle pseudohypertrophy ;###muscleSoftTissue,Dystrophic changes seen on muscle biopsy ;###muscleSoftTissue,Hypoglycosylation of alpha-dystroglycan seen on muscle biopsy ###neurologicCentralNervousSystem,Delayed psychomotor development (patient A) ;###neurologicCentralNervousSystem,Mental retardation (patient A) ;###neurologicCentralNervousSystem,Poor speech acquisition (patient A) ;###neurologicCentralNervousSystem,No structural brain anomalies ###laboratoryAbnormalities,Increased serum creatine kinase ###miscellaneous,Onset in early childhood ;###miscellaneous,Two unrelated patients have been reported (last curated August 2015) ;###miscellaneous,Patient B presented with asymptomatic increased serum creatine kinase and no clinical muscle symptoms ###molecularBasis,Caused by mutation in the dystrophin-associated glycoprotein 1 gene (DAG1, )",https://www.omim.org/entry/616538;https://www.omim.org/entry/613818,.,Autosomal recessive,Het,3,49547990,C,T,.,.,PASS,0/1:28:70,40.0,",..,.T..T...TT,+2tt,.TT,.,.T.TtTTtt..T,.t...,TT...TTT,T..TT,..T.TT^].",missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant;missense_variant,DAG1,1605,.,NM_001177634.2(DAG1):c.23C>T(p.Ser8Leu);NM_001165928.3(DAG1):c.23C>T(p.Ser8Leu);NM_001177641.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177636.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177640.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177644.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177635.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177643.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177638.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177637.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177642.2(DAG1):c.23C>T(p.Ser8Leu);NM_001177639.2(DAG1):c.23C>T(p.Ser8Leu);NM_004393.5(DAG1):c.23C>T(p.Ser8Leu),NM_004393.5,exon5(6);exon5(6);exon3(4);exon4(5);exon3(4);exon2(3);exon3(4);exon2(3);exon3(4);exon3(4);exon3(4);exon2(3);exon2(3),P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP;P0=>NP,0.001,0.0002,0,0,1.631e-05,0,.,.,0,0,0,0,3,0.000025,0.00614754098361,3/488,http://exac.broadinstitute.org/variant/3-49547990-C-T,1.07,13.1,1,0.94,http://exac.broadinstitute.org/gene/ENSG00000173402,0.10349,.,0.38,T,0.0,B,0.0,B,0.195,N,1.000,N,-3.21,5.467,rs199501149,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,basement membrane organization (GO:0071711)|branching involved in salivary gland morphogenesis (GO:0060445)|calcium-dependent cell-matrix adhesion (GO:0016340)|commissural neuron axon guidance (GO:0071679)|cytoskeletal anchoring at plasma membrane (GO:0007016)|epithelial tube branching involved in lung morphogenesis (GO:0060441)|extracellular matrix organization (GO:0030198)|membrane protein ectodomain proteolysis (GO:0006509)|microtubule anchoring (GO:0034453)|modulation by virus of host morphology or physiology (GO:0019048)|morphogenesis of an epithelial sheet (GO:0002011)|myelination in peripheral nervous system (GO:0022011)|negative regulation of cell migration (GO:0030336)|negative regulation of MAPK cascade (GO:0043409)|negative regulation of protein kinase B signaling (GO:0051898)|nerve maturation (GO:0021682)|NLS-bearing protein import into nucleus (GO:0006607)|response to peptide hormone (GO:0043434),basement membrane (GO:0005604)|basolateral plasma membrane (GO:0016323)|cell outer membrane (GO:0009279)|cell-cell adherens junction (GO:0005913)|contractile ring (GO:0070938)|costamere (GO:0043034)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|dystroglycan complex (GO:0016011)|dystrophin-associated glycoprotein complex (GO:0016010)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|filopodium (GO:0030175)|focal adhesion (GO:0005925)|integral component of membrane (GO:0016021)|lamellipodium (GO:0030027)|membrane raft (GO:0045121)|node of Ranvier (GO:0033268)|nucleoplasm (GO:0005654)|plasma membrane (GO:0005886)|postsynaptic membrane (GO:0045211)|sarcolemma (GO:0042383),actin binding (GO:0003779)|alpha-actinin binding (GO:0051393)|calcium ion binding (GO:0005509)|laminin-1 binding (GO:0043237)|SH2 domain binding (GO:0042169)|structural constituent of muscle (GO:0008307)|tubulin binding (GO:0015631)|vinculin binding (GO:0017166)|virus receptor activity (GO:0001618),.,.,.,.,49,2,OSS17011400102
430,.,.,OMIM|truncating|novel|possible_comhet,.,.,OSS17011400102,604145;613765;608807;611705;603689;600334,"Cardiomyopathy, dilated, 1G;Cardiomyopathy, familial hypertrophic, 9;Muscular dystrophy, limb-girdle, type 2J;Myopathy, early-onset, with fatal cardiomyopathy;Myopathy, proximal, with early respiratory muscle involvement;Tibial muscular dystrophy, tardive","1.$$$mimNumber,608807###prefix,####preferredTitle,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J###inheritance,Autosomal recessive ###cardiovascularHeart,No cardiomyopathy ###muscleSoftTissue,Proximal muscle weakness ;###muscleSoftTissue,Distal muscle weakness, mild ;###muscleSoftTissue,Severe disability within 20 years of onset ;###muscleSoftTissue,Loss of ambulation between third and sixth decade ;###muscleSoftTissue,No facial muscle involvement ;###muscleSoftTissue,EMG shows myopathic changes ;###muscleSoftTissue,Muscle biopsy shows dystrophic changes ;###muscleSoftTissue,Fatty infiltration of affected muscles ;###muscleSoftTissue,Secondary decrease of calpain-3 (CAPN3, ) protein expression in muscle###laboratoryAbnormalities,Normal or increased serum creatine kinase ###miscellaneous,Childhood-onset ;###miscellaneous,Heterozygous titin mutation causes the less-severe tardive tibial muscular dystrophy ();###miscellaneous,Allelic disorder to a form of dilated cardiomyopathy (CMD1G, )###molecularBasis,Caused by mutation in the titin gene (TTN, ) 2.$$$mimNumber,611705###prefix,####preferredTitle,MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; EOMFC###inheritance,Autosomal recessive ###headAndNeckFace,Facial muscle weakness ###headAndNeckEyes,Ptosis ###cardiovascularHeart,Dilated cardiomyopathy ;###cardiovascularHeart,Arrhythmia ###muscleSoftTissue,Delayed motor development ;###muscleSoftTissue,Muscle weakness, generalized, proximal and distal ;###muscleSoftTissue,Calf hypertrophy ;###muscleSoftTissue,Muscle biopsy shows centralized nuclei ;###muscleSoftTissue,Type 1 fiber predominance ;###muscleSoftTissue,Minicore-like lesions with mitochondrial depletion and sarcomeric disorganization ;###muscleSoftTissue,Disruption of the M-line ;###muscleSoftTissue,Dystrophic changes occur later ###laboratoryAbnormalities,Serum creatine kinase may be increased ###miscellaneous,Muscle involvement shows onset at birth or in infancy ;###miscellaneous,Cardiac involvement occurs between 5 and 12 years ;###miscellaneous,Sudden death due to cardiomyopathy ###molecularBasis,Caused by mutation in the titin gene (TTN, ) 3.$$$mimNumber,600334###prefix,####preferredTitle,TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD###inheritance,Autosomal dominant ###muscleSoftTissue,Weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) ;###muscleSoftTissue,Atrophy of the muscles in the anterior compartment of the lower leg ;###muscleSoftTissue,'Steppage' gait ;###muscleSoftTissue,Reduced ankle dorsiflexion ;###muscleSoftTissue,Replacement of affected muscle tissue with fatty tissue ;###muscleSoftTissue,Biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size ;###muscleSoftTissue,Myopathy seen on EMG ###miscellaneous,Adult onset (after age 35 years) ;###miscellaneous,Slow progression without marked disability ;###miscellaneous,Incomplete penetrance ;###miscellaneous,Cardiomyopathy is not a feature ###molecularBasis,Caused by heterozygous mutation in the titin gene (TTN, )",https://www.omim.org/entry/604145;https://www.omim.org/entry/613765;https://www.omim.org/entry/608807;https://www.omim.org/entry/611705;https://www.omim.org/entry/603689;https://www.omim.org/entry/600334,.,Autosomal recessive;Autosomal dominant,Het,2,179474647,C,T,.,.,PASS,0/1:101:219,46.12,".$.$T$.$,$,$tt,TTTTt,t,tT,.T,t,.,,TTT.,t,T.,tt.T,tTT..,T.tT.,t,t,.t,.T.,,,t.tTTtTTt.t,ttt.T,,,tt,,TTT...t,t,t,,.tT.Tt.,T.tt,..,,,,,.T...,t,t,..T.T..,,TT.t,,tTT,t..Tttt.T,,T,..,tt.Tt,...tTTT.t,.t,t,T.^]T^],^],",stop_gained;stop_gained;stop_gained;stop_gained;stop_gained;stop_gained,TTN,7273,.,NM_133378.4(TTN):c.43799G>A(p.Trp14600Ter);NM_001267550.1(TTN):c.51503G>A(p.Trp17168Ter);NM_133437.3(TTN):c.24884G>A(p.Trp8295Ter);NM_001256850.1(TTN):c.46580G>A(p.Trp15527Ter);NM_133432.3(TTN):c.24683G>A(p.Trp8228Ter);NM_003319.4(TTN):c.24308G>A(p.Trp8103Ter),NM_133378.4,exon221(312);exon272(363);exon101(192);exon222(313);exon101(192);exon100(191),NP=>.;NP=>.;NP=>.;NP=>.;NP=>.;NP=>.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-5.48,893.9,247,0.0,http://exac.broadinstitute.org/gene/ENSG00000155657,0.99985,.,0,D,.,.,.,.,.,.,1.000,A,5.7,60,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,adult heart development (GO:0007512)|blood coagulation (GO:0007596)|cardiac muscle contraction (GO:0060048)|cardiac muscle fiber development (GO:0048739)|cardiac muscle hypertrophy (GO:0003300)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac myofibril assembly (GO:0055003)|detection of muscle stretch (GO:0035995)|forward locomotion (GO:0043056)|in utero embryonic development (GO:0001701)|mitotic chromosome condensation (GO:0007076)|muscle contraction (GO:0006936)|muscle filament sliding (GO:0030049)|platelet activation (GO:0030168)|platelet degranulation (GO:0002576)|regulation of catalytic activity (GO:0050790)|regulation of protein kinase activity (GO:0045859)|regulation of relaxation of cardiac muscle (GO:1901897)|response to calcium ion (GO:0051592)|sarcomere organization (GO:0045214)|sarcomerogenesis (GO:0048769)|skeletal muscle myosin thick filament assembly (GO:0030241)|skeletal muscle thin filament assembly (GO:0030240)|somitogenesis (GO:0001756)|striated muscle contraction (GO:0006941),condensed nuclear chromosome (GO:0000794)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|I band (GO:0031674)|M band (GO:0031430)|nucleus (GO:0005634)|striated muscle thin filament (GO:0005865)|Z disc (GO:0030018),actin filament binding (GO:0051015)|actinin binding (GO:0042805)|ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|enzyme binding (GO:0019899)|identical protein binding (GO:0042802)|muscle alpha-actinin binding (GO:0051371)|protease binding (GO:0002020)|protein kinase binding (GO:0019901)|protein self-association (GO:0043621)|protein serine/threonine kinase activity (GO:0004674)|structural constituent of muscle (GO:0008307)|structural molecule activity conferring elasticity (GO:0097493)|telethonin binding (GO:0031433),.,.,.,.,7,1,OSS17011400102
445,.,.,HGMD|OMIM,.,.,OSS17011400102,158810;616411;254090,Bethlem myopathy 1;Dystonia 27;Ullrich congenital muscular dystrophy 1,"1.$$$mimNumber,158810###prefix,####preferredTitle,BETHLEM MYOPATHY 1; BTHLM1###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###headAndNeckNeck,Torticollis, congenital ###cardiovascularHeart,No cardiac involvement ###respiratory,Respiratory failure due to muscle weakness may occur in late stages ###skeletal,Contractures ###skeletalLimbs,Contractures of the elbows ;###skeletalLimbs,Contractures of the ankles ###skeletalHands,Long finger flexion contractures of the last four fingers ###muscleSoftTissue,Delayed motor milestones ;###muscleSoftTissue,Muscle weakness, limb-girdle ;###muscleSoftTissue,Proximal muscle weakness more severe than distal muscle weakness ;###muscleSoftTissue,Extensor muscle weakness more severe than flexor muscle weakness ;###muscleSoftTissue,Muscle atrophy, mild, more proximal than distal ;###muscleSoftTissue,Hypotonia, in neonatal onset ;###muscleSoftTissue,Muscle biopsy shows nonspecific myopathic changes ###prenatalManifestationsMovement,Decreased fetal movements may occur ###laboratoryAbnormalities,Normal or increased serum creatine kinase ###miscellaneous,Variable severity ;###miscellaneous,Onset usually in early childhood, although ranges from birth to adulthood ;###miscellaneous,Slow progression ;###miscellaneous,Approximately half of patients need ambulatory support after the fifth decade ;###miscellaneous,Ullrich congenital muscular dystrophy () is an allelic disorder with autosomal recessive inheritance and a more severe phenotype###molecularBasis,Caused by mutation in the collagen VI, alpha-1 polypeptide gene (COL6A1, );###molecularBasis,Caused by mutation in the collagen VI, alpha-2 polypeptide gene (COL6A2, );###molecularBasis,Caused by mutation in the collagen VI, alpha-3 polypeptide gene (COL6A3, ) 2.$$$mimNumber,616411###prefix,####preferredTitle,DYSTONIA 27; DYT27###inheritance,Autosomal recessive ###headAndNeckMouth,Oromandibular dystonia ###respiratoryLarynx,Laryngeal dystonia ###neurologicCentralNervousSystem,Dystonia, isolated, segmental ;###neurologicCentralNervousSystem,Craniocervical predominance ;###neurologicCentralNervousSystem,Upper limb involvement ;###neurologicCentralNervousSystem,Writer's cramp ;###neurologicCentralNervousSystem,Postural tremor ;###neurologicCentralNervousSystem,Action tremor ;###neurologicCentralNervousSystem,Truncal dystonia ###miscellaneous,Onset in first or second decade ###molecularBasis,Caused by mutation in the collagen, type VI, alpha-3 gene (COL6A3, ) 3.$$$mimNumber,254090###prefix,####preferredTitle,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1###inheritance,Autosomal recessive ;###inheritance,Autosomal dominant ###growthWeight,Low weight due to poor feeding ###growthOther,Failure to thrive ;###growthOther,Slender build ###headAndNeckFace,Facial weakness, mild ;###headAndNeckFace,Round face ###headAndNeckEars,Prominent ears ###headAndNeckMouth,High-arched palate ###headAndNeckNeck,Torticollis ;###headAndNeckNeck,Neck weakness ###respiratory,Respiratory insufficiency due to muscle weakness often requiring ventilatory assistance ;###respiratory,Nocturnal hypoventilation ;###respiratory,Recurrent chest infections ###skeletal,Proximal joint contractures ;###skeletal,Distal joint laxity ###skeletalSpine,Spinal rigidity ;###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphosis ###skeletalPelvis,Hip dislocation ###skeletalLimbs,Long, thin limbs ;###skeletalLimbs,Increased laxity of wrists ;###skeletalLimbs,Increased laxity of ankles ###skeletalHands,Increased laxity of fingers ###skeletalFeet,Talipes equinovarus ;###skeletalFeet,Calcaneal protrusion ###skinNailsHairSkin,Hyperhidrosis ;###skinNailsHairSkin,Follicular hyperkeratosis ###muscleSoftTissue,Hypotonia, neonatal ;###muscleSoftTissue,Muscle weakness, proximal greater than distal ;###muscleSoftTissue,Generalized muscle atrophy ;###muscleSoftTissue,Delayed motor milestones ;###muscleSoftTissue,Delayed ambulation ;###muscleSoftTissue,Some patients never achieve ambulation ;###muscleSoftTissue,Muscle biopsy shows increased variation in fiber size ;###muscleSoftTissue,Muscle biopsy shows type 1 fiber predominance ;###muscleSoftTissue,Muscle biopsy shows merosin ()-positive muscle fibers;###muscleSoftTissue,Absence of collagen VI immunostaining ;###muscleSoftTissue,Increased endo- and perimysial connective tissue ;###muscleSoftTissue,Muscle fiber necrosis ;###muscleSoftTissue,Muscle fiber regeneration ###neurologicCentralNervousSystem,Normal intelligence ###neurologicPeripheralNervousSystem,Decreased or absent reflexes due to muscle weakness ###laboratoryAbnormalities,Normal to mildly increased serum creatine kinase ###miscellaneous,Onset in infancy ;###miscellaneous,Variable severity ;###miscellaneous,Progressive disorder ;###miscellaneous,Bethlem myopathy () is an allelic disorder with a milder phenotype and autosomal dominant inheritance;###miscellaneous,A subset of patients have heterozygous mutations consistent with a dominant-negative effect ###molecularBasis,Caused by mutation in the collagen VI, alpha-1 polypeptide gene (COL6A1, );###molecularBasis,Caused by mutation in the collagen VI, alpha-2 polypeptide gene (COL6A2, );###molecularBasis,Caused by mutation in the collagen VI, alpha-3 polypeptide gene (COL6A3, )",https://www.omim.org/entry/158810;https://www.omim.org/entry/616411;https://www.omim.org/entry/254090,.,"Autosomal recessive, Autosomal dominant;Autosomal recessive",Het,2,238245008,G,A,.,.,PASS,0/1:77:168,45.83,".Aa.,...A.a.A..A.Aa.a.,...AA.AAA.aaaAAA.A.AaaA...a,,A,,..,.,....,....,.AAaa.a.A.a,aA.A,AaAA,,a..aa.A.A..,....AA,.A.A.,,,a.AA,,,AA,,A,AAA..aaa,aAAA,Aaaa^].^],",missense_variant;missense_variant;missense_variant,COL6A3,1293,.,NM_057167.3(COL6A3):c.8117C>T(p.Pro2706Leu);NM_057166.4(COL6A3):c.6914C>T(p.Pro2305Leu);NM_004369.3(COL6A3):c.8735C>T(p.Pro2912Leu),NM_004369.3,exon39(43);exon37(41);exon40(44),NP=>NP;NP=>NP;NP=>NP,0.028,0.0068,9,0.00069,0.0062,0.0321,0.0074,0.0339,10,261,0.030,15,714,0.0059,0.0799180327869,39/488,http://exac.broadinstitute.org/variant/2-238245008-G-A,-0.3,89.0,34,0.0,http://exac.broadinstitute.org/gene/ENSG00000163359,0.05983,5.82E-4,0.19,T,0.999,D,0.96,D,0.661,N,1.000,N,0.764,2.880,rs112928650,.,.,.,.,.,.,.,.,.,.,.,.,"NM_004369.3(COL6A3):c.8737delG,DM,Collagen VI deficiency,17785673",166936,https://www.ncbi.nlm.nih.gov/clinvar/variation/166936,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,axon guidance (GO:0007411)|cell adhesion (GO:0007155)|collagen catabolic process (GO:0030574)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|muscle organ development (GO:0007517)|response to glucose (GO:0009749),collagen type VI trimer (GO:0005589)|endoplasmic reticulum lumen (GO:0005788)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|proteinaceous extracellular matrix (GO:0005578)|sarcolemma (GO:0042383)|vesicle (GO:0031982),serine-type endopeptidase inhibitor activity (GO:0004867),.,.,.,.,5,0,OSS17011400102
544,.,.,HGMD|OMIM|low_frequency,.,.,OSS17011400102,602099;616668;604360,"Amyotrophic lateral sclerosis 5, juvenile;Charcot-Marie-Tooth disease, axonal, type 2X;Spastic paraplegia 11, autosomal recessive","1.$$$mimNumber,602099###prefix,####preferredTitle,AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5###inheritance,Autosomal recessive ###headAndNeckFace,Increased facial reflexes ;###headAndNeckFace,Jaw spasticity ;###headAndNeckFace,Weak masseter muscles ###headAndNeckMouth,Tongue weakness ;###headAndNeckMouth,Poor palatal elevation ###respiratory,Respiratory failure due to muscle weakness ###muscleSoftTissue,Distal muscle weakness ;###muscleSoftTissue,Distal muscle atrophy ;###muscleSoftTissue,Chronic neurogenic changes seen on EMG ;###muscleSoftTissue,Fibrillations ;###muscleSoftTissue,Fasciculations ###neurologicCentralNervousSystem,Upper motor neuron signs ;###neurologicCentralNervousSystem,Lower motor neuron signs ;###neurologicCentralNervousSystem,Pyramidal signs ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Bulbar signs ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,No cognitive impairment ;###neurologicCentralNervousSystem,No thinning of corpus callosum ;###neurologicCentralNervousSystem,Loss of anterior horn cells in the spinal cord ;###neurologicCentralNervousSystem,Loss of myelinated fibers in the anterolateral columns ###neurologicPeripheralNervousSystem,Decreased amplitude of compound muscle action potentials ###miscellaneous,Onset in first or second decade ;###miscellaneous,Slowly progressive ;###miscellaneous,Some patients may become wheelchair-bound ;###miscellaneous,Survival 30 to 40 years after onset ###molecularBasis,Caused by mutation in the spatacsin gene (SPG11, ) 2.$$$mimNumber,616668###prefix,####preferredTitle,CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X###inheritance,Autosomal recessive ###genitourinaryBladder,Urinary dysfunction (in some patients) ###skeletal,Ankle contractures (in some patients) ###skeletalSpine,Kyphoscoliosis (in some patients) ###skeletalHands,Hand deformities (in some patients) ###skeletalFeet,Foot deformities (in some patients) ;###skeletalFeet,Pes cavus (in some patients) ###muscleSoftTissue,Distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs ;###muscleSoftTissue,Distal muscle atrophy due to peripheral neuropathy, lower limbs more affected than upper limbs ;###muscleSoftTissue,Chronic denervation/reinnervation seen on EMG ###neurologicCentralNervousSystem,Tremor (in some patients) ;###neurologicCentralNervousSystem,Cognitive impairment, mild, (1 family) ;###neurologicCentralNervousSystem,Thin corpus callosum (1 family) ###neurologicPeripheralNervousSystem,Axonal neuropathy ;###neurologicPeripheralNervousSystem,Gait impairment due to neuropathy ;###neurologicPeripheralNervousSystem,Foot drop ;###neurologicPeripheralNervousSystem,Hypo- or areflexia ;###neurologicPeripheralNervousSystem,Distal sensory impairment ;###neurologicPeripheralNervousSystem,Normal or mildly decreased nerve conduction velocities ;###neurologicPeripheralNervousSystem,Decreased nerve action potentials ;###neurologicPeripheralNervousSystem,Sural nerve biopsy shows loss of large caliber myelinated fibers ###miscellaneous,Mean age at onset 11.4 years (range 4 to 35) ;###miscellaneous,Variable phenotype ;###miscellaneous,Slowly progressive ###molecularBasis,Caused by mutation in the SPG11 gene (SPG11, ) 3.$$$mimNumber,604360###prefix,####preferredTitle,SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11###inheritance,Autosomal recessive ###growthWeight,Obesity ###headAndNeckEyes,Nystagmus, gaze-evoked ;###headAndNeckEyes,Pigmented macular degeneration, adult-onset ;###headAndNeckEyes,Retinal degeneration, adult-onset ;###headAndNeckEyes,Decreased visual acuity, adult-onset ###genitourinaryBladder,Urinary urgency ;###genitourinaryBladder,Urinary incontinence ;###genitourinaryBladder,Sphincter disturbances ###skeletalFeet,Pes cavus ###muscleSoftTissue,Amyotrophy ;###muscleSoftTissue,Muscle atrophy, neurogenic ;###muscleSoftTissue,Atrophy of the thenar and hypothenar muscles ###neurologicCentralNervousSystem,Lower limb spasticity ;###neurologicCentralNervousSystem,Lower limb weakness ;###neurologicCentralNervousSystem,Walking on tiptoes ;###neurologicCentralNervousSystem,Stiffness while walking ;###neurologicCentralNervousSystem,Spastic gait ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Pyramidal signs ;###neurologicCentralNervousSystem,Knee and ankle clonus ;###neurologicCentralNervousSystem,Degeneration of the lateral corticospinal tracts ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Dysphagia ;###neurologicCentralNervousSystem,Learning disability (early in life) ;###neurologicCentralNervousSystem,Severe cognitive deficits (develop later) ;###neurologicCentralNervousSystem,Mental retardation (develops later) ;###neurologicCentralNervousSystem,Thin corpus callosum ;###neurologicCentralNervousSystem,Agenesis of the corpus callosum ;###neurologicCentralNervousSystem,Cortical atrophy ;###neurologicCentralNervousSystem,Periventricular white matter changes ###neurologicPeripheralNervousSystem,Peripheral motor and sensory neuropathy, distal ;###neurologicPeripheralNervousSystem,Decreased vibratory sense in the lower limbs ;###neurologicPeripheralNervousSystem,Nerve biopsy shows loss of myelinated fibers ###miscellaneous,Onset usually in early adolescence ;###miscellaneous,Adult onset has been reported (age 50 years) ;###miscellaneous,Childhood onset has been reported ;###miscellaneous,Progressive disorder ;###miscellaneous,Loss of ambulation within 10 years of onset ;###miscellaneous,Some patients do not have thin corpus callosum ;###miscellaneous,Several forms of autosomal recessive spastic paraplegia (see )###molecularBasis,Caused by mutation in the spatacsin gene (SPG11, )",https://www.omim.org/entry/602099;https://www.omim.org/entry/616668;https://www.omim.org/entry/604360,.,Autosomal recessive,Het,15,44949357,C,T,.,.,PASS,0/1:55:106,51.89,"T$T.TT.T.t..t..tT..Tt,TTTT,.T,.,T,TtT,...,.tTTT,.Tt,TT,T.T,.T..t,T.T..T.ttTT.TTTTT,,T.,.TTT",missense_variant;missense_variant,SPG11,80208,.,NM_025137.3(SPG11):c.805G>A(p.Asp269Asn);NM_001160227.1(SPG11):c.805G>A(p.Asp269Asn),NM_025137.3,exon4(40);exon4(38),P-=>P0;P-=>P0,.,.,0,0,1.625e-05,0.0002,.,.,0,2,0.00023,0,2,0.000017,.,.,http://exac.broadinstitute.org/variant/15-44949357-C-T,-2.96,75.9,47,0.0,http://exac.broadinstitute.org/gene/ENSG00000104133,0.51164,.,0.08,T,0.999,D,0.839,P,0.000,D,0.938,N,5.71,15.48,.,.,.,.,.,NM_025137.3(SPG11):c.805G>A(p.D269N),DM?,"Amyotrophic lateral sclerosis, sporadic",26742954,.,.,.,.,"NM_025137.3(SPG11):c.808G>A(p.V270I),DM?,Amyotrophic lateral sclerosis,25588603",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell death (GO:0008219),cytoplasm (GO:0005737)|cytoplasmic vesicle (GO:0031410)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|nucleolus (GO:0005730)|plasma membrane (GO:0005886),.,.,.,.,.,97,5,OSS17011400102
608,.,.,HGMD|OMIM,.,.,OSS17011400102,601382,"Charcot-Marie-Tooth disease, type 4B1","1.$$$mimNumber,601382###prefix,####preferredTitle,CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1###inheritance,Autosomal recessive ###headAndNeckFace,Facial weakness ###skeletalSpine,Scoliosis may be present ###skeletalFeet,Talipes equinovarus ;###skeletalFeet,Foot deformities ###neurologicPeripheralNervousSystem,Delayed motor development ;###neurologicPeripheralNervousSystem,Distal limb muscle weakness due to peripheral neuropathy ;###neurologicPeripheralNervousSystem,Distal limb muscle atrophy due to peripheral neuropathy ;###neurologicPeripheralNervousSystem,Proximal limb muscle weakness ;###neurologicPeripheralNervousSystem,Facial weakness ;###neurologicPeripheralNervousSystem,Distal sensory impairment ;###neurologicPeripheralNervousSystem,Severely decreased motor nerve conduction velocity (NCV) (15 m/s) ;###neurologicPeripheralNervousSystem,Irregular loops and focal folding of myelin sheaths ;###neurologicPeripheralNervousSystem,Abnormal auditory evoked potentials ###miscellaneous,Mean age of onset 34 months ;###miscellaneous,Death in fourth to fifth decade ;###miscellaneous,Begins in feet and legs (peroneal distribution) ;###miscellaneous,Severe clinical course ;###miscellaneous,Genetic heterogeneity (see CMT4B2, ###molecularBasis,Caused by mutation in the myotubularin-related protein-2 gene (MTMR2, )",https://www.omim.org/entry/601382,.,Autosomal recessive,Het,11,95568581,G,C,.,.,PASS,0/1:36:83,43.37,"c,,cC,.c,c,.,c.,cCCc,.c,,.CCc,cc,c,c,.C.,ccc.c,...cc.,,.,.ccC.cc,c,c,c,c,,,",missense_variant;missense_variant;missense_variant;missense_variant,MTMR2,8898,.,NM_201278.2(MTMR2):c.1589C>G(p.Ala530Gly);NM_001243571.1(MTMR2):c.1589C>G(p.Ala530Gly);NM_201281.2(MTMR2):c.1589C>G(p.Ala530Gly);NM_016156.5(MTMR2):c.1805C>G(p.Ala602Gly),NM_016156.5,exon17(17);exon18(18);exon16(16);exon15(15),NP=>P0;NP=>P0;NP=>P0;NP=>P0,0.025,0.005,0,0,0.0020,0.0275,0.0017,0.0309,6,261,0.030,6,268,0.0022,0.0655737704918,32/488,http://exac.broadinstitute.org/variant/11-95568581-G-C,1.1,33.0,8,0.21,http://exac.broadinstitute.org/gene/ENSG00000087053,0.70107,.,0.32,T,0.136,B,0.056,B,0.000,D,1.000,D,6.17,19.18,rs76784113,.,.,.,.,NM_016156.5(MTMR2):c.1805C>G(p.A602G),DM?,Congenital hypomyelinating neuropathy,11354824,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell death (GO:0008219)|dendritic spine maintenance (GO:0097062)|inositol phosphate dephosphorylation (GO:0046855)|myelin assembly (GO:0032288)|negative regulation of endocytosis (GO:0045806)|negative regulation of excitatory postsynaptic membrane potential (GO:0090394)|negative regulation of myelination (GO:0031642)|negative regulation of receptor catabolic process (GO:2000645)|negative regulation of receptor internalization (GO:0002091)|neuron development (GO:0048666)|phosphatidylinositol biosynthetic process (GO:0006661)|phosphatidylinositol dephosphorylation (GO:0046856)|phospholipid metabolic process (GO:0006644)|positive regulation of early endosome to late endosome transport (GO:2000643)|protein dephosphorylation (GO:0006470)|protein tetramerization (GO:0051262)|small molecule metabolic process (GO:0044281),axon (GO:0030424)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|dendrite (GO:0030425)|dendritic spine (GO:0043197)|endosome (GO:0005768)|neuronal postsynaptic density (GO:0097481)|nucleus (GO:0005634)|synaptic membrane (GO:0097060)|synaptic vesicle (GO:0008021)|vacuolar membrane (GO:0005774),"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity (GO:0052629)|phosphatidylinositol-3-phosphatase activity (GO:0004438)|protein tyrosine phosphatase activity (GO:0004725)|protein tyrosine/serine/threonine phosphatase activity (GO:0008138)",.,.,.,.,80,3,OSS17011400102
